The minimally invasive spine surgery devices market has seen considerable growth due to a variety of factors.
• The minimally invasive spine surgery devices market has grown strongly in recent years. It will grow from $1.11 billion in 2024 to $1.17 billion in 2025, at a CAGR of 5.5%.
This growth can be linked to increasing patient preference for minimally invasive procedures, growing clinical evidence supporting their efficacy, cost pressures on healthcare systems, and shifting surgical paradigms.
The minimally invasive spine surgery devices market is expected to maintain its strong growth trajectory in upcoming years.
• The minimally invasive spine surgery devices market is expected to grow robustly, reaching $1.43 billion by 2029 at a CAGR of 5.1%.
The growth is attributed to healthcare digitization, the adoption of electronic health records, the exploration of regenerative medicine, changing reimbursement policies, and more collaborations. Key trends include innovations in surgical instruments, imaging technologies, biocompatible materials, personalized medicine, remote monitoring, and VR/AR technology integration.
The rising frequency of spinal disorders is anticipated to drive the growth of minimally invasive spine surgery devices in the future. These disorders affect the spine and may result in pain, stiffness, or neurological issues. Contributing factors include aging, sedentary lifestyles, repetitive stress, and degenerative spinal changes. Minimally invasive spine surgery devices help by reducing tissue damage, shortening recovery times, and lessening post-operative pain compared to traditional surgery. For instance, in 2024, the National Spinal Cord Injury Statistical Center estimated that 305,000 individuals in the U.S. would be living with traumatic spinal cord injuries. The increasing incidence of spinal disorders is thus driving the growth of minimally invasive spine surgery devices.
The minimally invasive spine surgery devices market covered in this report is segmented –
1) By Product: Cervical Fusion Devices, Spine Biologics, Vertebral Compression Fracture Treatment Devices, Non-fusion Devices, Spine Bone Stimulators, Spinal Decompression Devices
2) By Treatment: Disk Herniation, Degenerative Spinal Disease, Spinal Stenosis, Other Treatments
3) By Procedure: Discectomy, Laminotomy, Foraminotomy, Facetectomy, Corpectomy
4) By Application: Fusion Surgery, Non-Fusion Surgery
5) By End User: Ambulatory Surgical Centers (ASCs), Hospitals
Subsegments:
1) By Cervical Fusion Devices: Anterior Cervical Discectomy And Fusion (ACDF) Devices, Posterior Cervical Fusion Devices, Cervical Spinal Plates, Cervical Screws And Rod Systems
2) By Spine Biologics: Bone Grafts And Bone Substitutes, Growth Factors And Stem Cells, Demineralized Bone Matrix (DBM), Synthetic Bone Grafts, Platelet-Rich Plasma (PRP), Osteobiologics For Spinal Fusion
3) By Vertebral Compression Fracture Treatment Devices: Vertebroplasty And Kyphoplasty Kits, Balloon Kyphoplasty Devices, Bone Cement For Vertebroplasty, Percutaneous Spinal Fracture Repair Devices
4) By Non-Fusion Devices: Dynamic Stabilization Systems, Artificial Discs (Lumbar And Cervical), Motion Preservation Devices, Total Disc Replacement Devices, Posterior Dynamic Stabilization Systems
5) By Spine Bone Stimulators: Non-Invasive Spine Bone Stimulators, Invasive Spine Bone Stimulators, Electromagnetic Bone Stimulators, Ultrasound Bone Stimulators, Pulsed Electromagnetic Field (PEMF) Devices
6) By Spinal Decompression Devices: Minimally Invasive Spinal Decompression Systems, Spinal Traction Devices, Percutaneous Discectomy Devices, Spinal Decompression Surgery Instruments, Spinal Distraction Devices
Key corporations in the minimally invasive spine surgery devices market, like Orthofix Medical Inc., are honing their focus on the creation of advanced products like adaptable retractor systems. Such systems can enhance surgical precision and boost patient outcomes by providing precise access, increased visibility, and minimizing tissue damage and recovery periods. In an example from April 2023, Orthofix Medical Inc., which is a medical device company based in the US, unveiled two novel retractor systems applicable for minimally invasive spine procedures. The Lattus Lateral Access System brings versatility in blade retraction and user ease, backing Orthofix's WaveForm L and Regatta NanoMetalene devices. Meanwhile, the Fathom Pedicle-Based Retractor System is equipped with three active telescoping blade fixations, enhancing visualization and precise customization with the least tissue disruption possible. Both of the introduced systems enhance surgical workflows and address distinct patient anatomy aspects.
Major companies operating in the minimally invasive spine surgery devices market are:
• Stryker Corporation
• Boston Scientific Corporation
• Zimmer Biomet Holdings Inc.
• NuVasive Inc.
• Globus Medical Inc.
• MicroPort Scientific Corporation
• Orthofix International N.V.
• Aesculap Inc.
• Alphatec Holdings Inc.
• SeaSpine Holdings Corporation
• RTI Surgical Inc.
• Spinal Elements
• Xtant Medical
• Precision Medical Inc.
• Spine Wave Inc.
• Zavation Medical Products LLC.
• Life Spine Inc.
• Nexxt Spine LLC
• CTL Amedica Corporation
• Intrinsic Therapeutics Inc
• Captiva Spine Inc.
• DePuy Synthes
• Osseus Fusion Systems
• SpineGuard S.A.
North America was the largest region in the minimally invasive spine surgery devices market in 2023. The regions covered in the minimally invasive spine surgery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.